Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary - Thomson StreetEvents

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary - Thomson StreetEvents
Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary
Published Nov 04, 2021
15 pages (7296 words) — Published Nov 04, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of IOVA.OQ earnings conference call or presentation 4-Nov-21 8:30pm GMT

  
Brief Excerpt:

...A. Overview: Continued to advance tumor infiltrating lymphocyte (TIL) platform into new indications in earlier treatment settings throughout this year. 1. a. For lead TIL product candidate, lifileucel in metastatic melanoma, top priority remains ongoing work to address FDA feedback regarding potency assays for lifileucel to support planned BLA submission. b. Continued ongoing work developing and validating potency assays and has engaged in discussions with FDA during 2H21. c. Anticipates BLA submission for lifileucel continues to be planned for 1H22. d. Remains confident in current guidance and timelines. e. Resolution of potency assays for lifileucel is important next regulatory step for cervical and non-small cell lung clinical programs. B. Clinical Pipeline: Now has clinical data showing promise of TIL therapy in four different solid tumor types from first line to late-stage treatment settings, furthering confidence in TIL as broad platform that may shift treatment paradigm for patients...

  
Report Type:

Brief

Source:
Company:
Iovance Biotherapeutics Inc
Ticker
IOVA.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Iovance Biotherapeutics Inc at JMP Group Hematology and Oncology Summit (Virtual) Transcript – 2021-12-07 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 7-Dec-21 6:40pm GMT

Iovance Biotherapeutics Inc at Stifel Healthcare Conference (Virtual) Transcript – 2021-11-17 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 17-Nov-21 4:20pm GMT

Iovance Biotherapeutics Inc at Cowen Immuno-Oncology Next Summit (Virtual) Transcript – 2021-11-15 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 15-Nov-21 8:45pm GMT

Iovance Biotherapeutics Inc to Discuss SITC Clinical Data Updates Transcript – 2021-11-13 – US$ 54.00 – Edited Transcript of IOVA.OQ corporate analyst meeting</ 13-Nov-21 10:30pm GMT

Iovance Biotherapeutics Inc Q3 2021 Earnings Call Transcript – 2021-11-04 – US$ 54.00 – Edited Transcript of IOVA.OQ earnings conference call or presentation 4-Nov-21 8:30pm GMT

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Summary – 2021-08-05 – US$ 54.00 – Edited Brief of IOVA.OQ earnings conference call or presentation 5-Aug-21 8:30pm GMT

Iovance Biotherapeutics Inc Q2 2021 Earnings Call Transcript – 2021-08-05 – US$ 54.00 – Edited Transcript of IOVA.OQ earnings conference call or presentation 5-Aug-21 8:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Summary – 2021-06-29 – US$ 54.00 – Edited Brief of IOVA.OQ conference call or presentation 29-Jun-21 8:30pm GMT

Iovance Biotherapeutics Inc to Discuss Clinical Data for LN-145 in Non-Small Cell Lung Cancer- Conference Call Transcript – 2021-06-29 – US$ 54.00 – Edited Transcript of IOVA.OQ conference call or presentation 29-Jun-21 8:30pm GMT

Iovance Biotherapeutics Inc at JMP Securities Life Sciences Virtual Conference Transcript – 2021-06-17 – US$ 54.00 – Edited Transcript of IOVA.OQ presentation 17-Jun-21 6:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary" Nov 04, 2021. Alacra Store. Apr 30, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-Iovance-Biotherapeutics-Inc-Earnings-Call-B15015593>
  
APA:
Thomson StreetEvents. (2021). Iovance Biotherapeutics Inc Q3 2021 Earnings Call Summary Nov 04, 2021. New York, NY: Alacra Store. Retrieved Apr 30, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-Iovance-Biotherapeutics-Inc-Earnings-Call-B15015593>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.